Pharma & Healthcare
Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2025
- Jan 21, 25
- ID: 808057
- Pages: 103
- Figures: 104
- Views: 4
The global market for BCG Vaccine for Tuberculosis (TB) was valued at US$ 80.4 million in the year 2024 and is projected to reach a revised size of US$ 99 million by 2031, growing at a CAGR of 3.1% during the forecast period.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.
A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.
Report Scope
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Tuberculosis (TB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine for Tuberculosis (TB).
The BCG Vaccine for Tuberculosis (TB) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BCG Vaccine for Tuberculosis (TB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Vaccine for Tuberculosis (TB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
IVAC – Institute of Vaccines and Medical Biologicals
Institut Pasteur de Tunis
Segment by Type
Immune Type
Therapy Type
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Vaccine for Tuberculosis (TB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Vaccine for Tuberculosis (TB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.
A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.
Report Scope
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Tuberculosis (TB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine for Tuberculosis (TB).
The BCG Vaccine for Tuberculosis (TB) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BCG Vaccine for Tuberculosis (TB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Vaccine for Tuberculosis (TB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
IVAC – Institute of Vaccines and Medical Biologicals
Institut Pasteur de Tunis
Segment by Type
Immune Type
Therapy Type
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Vaccine for Tuberculosis (TB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Vaccine for Tuberculosis (TB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 BCG Vaccine for Tuberculosis (TB) Market Overview
1.1 Product Definition
1.2 BCG Vaccine for Tuberculosis (TB) by Type
1.2.1 Global BCG Vaccine for Tuberculosis (TB) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immune Type
1.2.3 Therapy Type
1.3 BCG Vaccine for Tuberculosis (TB) by Application
1.3.1 Global BCG Vaccine for Tuberculosis (TB) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global BCG Vaccine for Tuberculosis (TB) Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine for Tuberculosis (TB) Revenue 2020-2031
1.4.2 Global BCG Vaccine for Tuberculosis (TB) Sales 2020-2031
1.4.3 Global BCG Vaccine for Tuberculosis (TB) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 BCG Vaccine for Tuberculosis (TB) Market Competition by Manufacturers
2.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2020-2025)
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of BCG Vaccine for Tuberculosis (TB), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Product Type & Application
2.7 Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Date of Enter into This Industry
2.8 Global BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
2.8.1 Global BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
2.8.3 Global BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global BCG Vaccine for Tuberculosis (TB) Market Scenario by Region
3.1 Global BCG Vaccine for Tuberculosis (TB) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Region: 2020-2031
3.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region: 2020-2025
3.2.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Region: 2026-2031
3.3 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2020-2031
3.3.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2020-2025
3.3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2026-2031
3.4 North America BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.4.1 North America BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.4.3 North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.5.1 Europe BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.5.3 Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Region
3.6.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2031)
3.6.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.7.1 Latin America BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.7.3 Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.8.3 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2031)
4.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2025)
4.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2026-2031)
4.1.3 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2020-2031)
4.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2020-2031)
4.2.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2020-2025)
4.2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2026-2031)
4.2.3 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2020-2031)
4.3 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2020-2031)
5 Segment by Application
5.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2031)
5.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2025)
5.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2026-2031)
5.1.3 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2020-2031)
5.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2020-2031)
5.2.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2020-2025)
5.2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2026-2031)
5.2.3 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2020-2031)
5.3 Global BCG Vaccine for Tuberculosis (TB) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 China National Biotec
6.3.1 China National Biotec Company Information
6.3.2 China National Biotec Description and Business Overview
6.3.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.3.5 China National Biotec Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 BioFarma
6.6.1 BioFarma Company Information
6.6.2 BioFarma Description and Business Overview
6.6.3 BioFarma BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioFarma BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.6.5 BioFarma Recent Developments/Updates
6.7 GSBPL
6.7.1 GSBPL Company Information
6.7.2 GSBPL Description and Business Overview
6.7.3 GSBPL BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GSBPL BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Company Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 ANLIS Malbran
6.11.1 ANLIS Malbran Company Information
6.11.2 ANLIS Malbran Description and Business Overview
6.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.11.5 ANLIS Malbran Recent Developments/Updates
6.12 Fundação Ataulpho de Paiva
6.12.1 Fundação Ataulpho de Paiva Company Information
6.12.2 Fundação Ataulpho de Paiva Description and Business Overview
6.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
6.13 BB-NCIPD
6.13.1 BB-NCIPD Company Information
6.13.2 BB-NCIPD Description and Business Overview
6.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.13.5 BB-NCIPD Recent Developments/Updates
6.14 Torlakinstitut
6.14.1 Torlakinstitut Company Information
6.14.2 Torlakinstitut Description and Business Overview
6.14.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.14.5 Torlakinstitut Recent Developments/Updates
6.15 IVAC – Institute of Vaccines and Medical Biologicals
6.15.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
6.15.2 IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
6.15.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.15.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.16 Institut Pasteur de Tunis
6.16.1 Institut Pasteur de Tunis Company Information
6.16.2 Institut Pasteur de Tunis Description and Business Overview
6.16.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.16.5 Institut Pasteur de Tunis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
7.2 BCG Vaccine for Tuberculosis (TB) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Vaccine for Tuberculosis (TB) Production Mode & Process Analysis
7.4 BCG Vaccine for Tuberculosis (TB) Sales and Marketing
7.4.1 BCG Vaccine for Tuberculosis (TB) Sales Channels
7.4.2 BCG Vaccine for Tuberculosis (TB) Distributors
7.5 BCG Vaccine for Tuberculosis (TB) Customer Analysis
8 BCG Vaccine for Tuberculosis (TB) Market Dynamics
8.1 BCG Vaccine for Tuberculosis (TB) Industry Trends
8.2 BCG Vaccine for Tuberculosis (TB) Market Drivers
8.3 BCG Vaccine for Tuberculosis (TB) Market Challenges
8.4 BCG Vaccine for Tuberculosis (TB) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 BCG Vaccine for Tuberculosis (TB) by Type
1.2.1 Global BCG Vaccine for Tuberculosis (TB) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immune Type
1.2.3 Therapy Type
1.3 BCG Vaccine for Tuberculosis (TB) by Application
1.3.1 Global BCG Vaccine for Tuberculosis (TB) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global BCG Vaccine for Tuberculosis (TB) Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine for Tuberculosis (TB) Revenue 2020-2031
1.4.2 Global BCG Vaccine for Tuberculosis (TB) Sales 2020-2031
1.4.3 Global BCG Vaccine for Tuberculosis (TB) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 BCG Vaccine for Tuberculosis (TB) Market Competition by Manufacturers
2.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2020-2025)
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of BCG Vaccine for Tuberculosis (TB), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Product Type & Application
2.7 Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Date of Enter into This Industry
2.8 Global BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
2.8.1 Global BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
2.8.3 Global BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global BCG Vaccine for Tuberculosis (TB) Market Scenario by Region
3.1 Global BCG Vaccine for Tuberculosis (TB) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Region: 2020-2031
3.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region: 2020-2025
3.2.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Region: 2026-2031
3.3 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2020-2031
3.3.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2020-2025
3.3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2026-2031
3.4 North America BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.4.1 North America BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.4.3 North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.5.1 Europe BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.5.3 Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Region
3.6.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2031)
3.6.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.7.1 Latin America BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.7.3 Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2031)
3.8.3 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2031)
4.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2025)
4.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2026-2031)
4.1.3 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2020-2031)
4.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2020-2031)
4.2.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2020-2025)
4.2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2026-2031)
4.2.3 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2020-2031)
4.3 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2020-2031)
5 Segment by Application
5.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2031)
5.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2025)
5.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2026-2031)
5.1.3 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2020-2031)
5.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2020-2031)
5.2.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2020-2025)
5.2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2026-2031)
5.2.3 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2020-2031)
5.3 Global BCG Vaccine for Tuberculosis (TB) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 China National Biotec
6.3.1 China National Biotec Company Information
6.3.2 China National Biotec Description and Business Overview
6.3.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.3.5 China National Biotec Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 BioFarma
6.6.1 BioFarma Company Information
6.6.2 BioFarma Description and Business Overview
6.6.3 BioFarma BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioFarma BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.6.5 BioFarma Recent Developments/Updates
6.7 GSBPL
6.7.1 GSBPL Company Information
6.7.2 GSBPL Description and Business Overview
6.7.3 GSBPL BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GSBPL BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Company Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 ANLIS Malbran
6.11.1 ANLIS Malbran Company Information
6.11.2 ANLIS Malbran Description and Business Overview
6.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.11.5 ANLIS Malbran Recent Developments/Updates
6.12 Fundação Ataulpho de Paiva
6.12.1 Fundação Ataulpho de Paiva Company Information
6.12.2 Fundação Ataulpho de Paiva Description and Business Overview
6.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
6.13 BB-NCIPD
6.13.1 BB-NCIPD Company Information
6.13.2 BB-NCIPD Description and Business Overview
6.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.13.5 BB-NCIPD Recent Developments/Updates
6.14 Torlakinstitut
6.14.1 Torlakinstitut Company Information
6.14.2 Torlakinstitut Description and Business Overview
6.14.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.14.5 Torlakinstitut Recent Developments/Updates
6.15 IVAC – Institute of Vaccines and Medical Biologicals
6.15.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
6.15.2 IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
6.15.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.15.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.16 Institut Pasteur de Tunis
6.16.1 Institut Pasteur de Tunis Company Information
6.16.2 Institut Pasteur de Tunis Description and Business Overview
6.16.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.16.5 Institut Pasteur de Tunis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
7.2 BCG Vaccine for Tuberculosis (TB) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Vaccine for Tuberculosis (TB) Production Mode & Process Analysis
7.4 BCG Vaccine for Tuberculosis (TB) Sales and Marketing
7.4.1 BCG Vaccine for Tuberculosis (TB) Sales Channels
7.4.2 BCG Vaccine for Tuberculosis (TB) Distributors
7.5 BCG Vaccine for Tuberculosis (TB) Customer Analysis
8 BCG Vaccine for Tuberculosis (TB) Market Dynamics
8.1 BCG Vaccine for Tuberculosis (TB) Industry Trends
8.2 BCG Vaccine for Tuberculosis (TB) Market Drivers
8.3 BCG Vaccine for Tuberculosis (TB) Market Challenges
8.4 BCG Vaccine for Tuberculosis (TB) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global BCG Vaccine for Tuberculosis (TB) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global BCG Vaccine for Tuberculosis (TB) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global BCG Vaccine for Tuberculosis (TB) Market Competitive Situation by Manufacturers in 2024
Table 4. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of BCG Vaccine for Tuberculosis (TB), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Product Type & Application
Table 12. Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global BCG Vaccine for Tuberculosis (TB) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global BCG Vaccine for Tuberculosis (TB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2025) & (K Dose)
Table 18. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2020-2025)
Table 19. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2026-2031) & (K Dose)
Table 20. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2026-2031)
Table 21. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2020-2025)
Table 23. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2026-2031)
Table 25. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 27. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 28. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 32. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 33. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Type (2020-2025)
Table 51. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Type (2026-2031)
Table 52. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2020-2025)
Table 53. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2026-2031)
Table 54. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2020-2025)
Table 57. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2026-2031)
Table 58. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Type (2020-2025)
Table 59. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Type (2026-2031)
Table 60. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Application (2020-2025)
Table 61. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Application (2026-2031)
Table 62. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2020-2025)
Table 63. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2026-2031)
Table 64. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2020-2025)
Table 67. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2026-2031)
Table 68. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Application (2020-2025)
Table 69. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Merck BCG Vaccine for Tuberculosis (TB) Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Company Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. China National Biotec Company Information
Table 81. China National Biotec Description and Business Overview
Table 82. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. China National Biotec BCG Vaccine for Tuberculosis (TB) Product
Table 84. China National Biotec Recent Developments/Updates
Table 85. AJ Vaccines Company Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. Serum Institute of India Company Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. BioFarma Company Information
Table 96. BioFarma Description and Business Overview
Table 97. BioFarma BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. BioFarma BCG Vaccine for Tuberculosis (TB) Product
Table 99. BioFarma Recent Developments/Updates
Table 100. GSBPL Company Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. GSBPL BCG Vaccine for Tuberculosis (TB) Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Biomed Lublin Company Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Company Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. ANLIS Malbran Company Information
Table 121. ANLIS Malbran Description and Business Overview
Table 122. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product
Table 124. ANLIS Malbran Recent Developments/Updates
Table 125. Fundação Ataulpho de Paiva Company Information
Table 126. Fundação Ataulpho de Paiva Description and Business Overview
Table 127. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product
Table 129. Fundação Ataulpho de Paiva Recent Developments/Updates
Table 130. BB-NCIPD Company Information
Table 131. BB-NCIPD Description and Business Overview
Table 132. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product
Table 134. BB-NCIPD Recent Developments/Updates
Table 135. Torlakinstitut Company Information
Table 136. Torlakinstitut Description and Business Overview
Table 137. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product
Table 139. Torlakinstitut Recent Developments/Updates
Table 140. IVAC – Institute of Vaccines and Medical Biologicals Company Information
Table 141. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
Table 142. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 143. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Product
Table 144. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
Table 145. Institut Pasteur de Tunis Company Information
Table 146. Institut Pasteur de Tunis Description and Business Overview
Table 147. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 148. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product
Table 149. Institut Pasteur de Tunis Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. BCG Vaccine for Tuberculosis (TB) Distributors List
Table 153. BCG Vaccine for Tuberculosis (TB) Customers List
Table 154. BCG Vaccine for Tuberculosis (TB) Market Trends
Table 155. BCG Vaccine for Tuberculosis (TB) Market Drivers
Table 156. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 157. BCG Vaccine for Tuberculosis (TB) Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Global BCG Vaccine for Tuberculosis (TB) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type: 2024 & 2031
Figure 4. Immune Type Product Picture
Figure 5. Therapy Type Product Picture
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global BCG Vaccine for Tuberculosis (TB) Market Size (2020-2031) & (US$ Million)
Figure 13. Global BCG Vaccine for Tuberculosis (TB) Sales (2020-2031) & (K Dose)
Figure 14. Global BCG Vaccine for Tuberculosis (TB) Average Price (US$/Dose) & (2020-2031)
Figure 15. BCG Vaccine for Tuberculosis (TB) Report Years Considered
Figure 16. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2024
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players: Market Share by Revenue in BCG Vaccine for Tuberculosis (TB) in 2024
Figure 19. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global BCG Vaccine for Tuberculosis (TB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 22. North America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 23. United States BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 26. Europe BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 27. Germany BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2020-2031)
Figure 34. China BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 44. Latin America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 45. Mexico BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 50. Turkey BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2020-2031)
Figure 54. Global Revenue Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2020-2031)
Figure 55. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Application (2020-2031)
Figure 57. Global Revenue Market Share of BCG Vaccine for Tuberculosis (TB) by Application (2020-2031)
Figure 58. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Application (2020-2031)
Figure 59. BCG Vaccine for Tuberculosis (TB) Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global BCG Vaccine for Tuberculosis (TB) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global BCG Vaccine for Tuberculosis (TB) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global BCG Vaccine for Tuberculosis (TB) Market Competitive Situation by Manufacturers in 2024
Table 4. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of BCG Vaccine for Tuberculosis (TB), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Product Type & Application
Table 12. Global Key Manufacturers of BCG Vaccine for Tuberculosis (TB), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global BCG Vaccine for Tuberculosis (TB) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global BCG Vaccine for Tuberculosis (TB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2025) & (K Dose)
Table 18. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2020-2025)
Table 19. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2026-2031) & (K Dose)
Table 20. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2026-2031)
Table 21. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2020-2025)
Table 23. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2026-2031)
Table 25. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 27. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 28. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 32. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 33. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Type (2020-2025)
Table 51. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Type (2026-2031)
Table 52. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2020-2025)
Table 53. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2026-2031)
Table 54. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2020-2025)
Table 57. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2026-2031)
Table 58. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Type (2020-2025)
Table 59. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Type (2026-2031)
Table 60. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Application (2020-2025)
Table 61. Global BCG Vaccine for Tuberculosis (TB) Sales (K Dose) by Application (2026-2031)
Table 62. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2020-2025)
Table 63. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2026-2031)
Table 64. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2020-2025)
Table 67. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2026-2031)
Table 68. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Application (2020-2025)
Table 69. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Merck BCG Vaccine for Tuberculosis (TB) Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Company Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. China National Biotec Company Information
Table 81. China National Biotec Description and Business Overview
Table 82. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. China National Biotec BCG Vaccine for Tuberculosis (TB) Product
Table 84. China National Biotec Recent Developments/Updates
Table 85. AJ Vaccines Company Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. Serum Institute of India Company Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. BioFarma Company Information
Table 96. BioFarma Description and Business Overview
Table 97. BioFarma BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. BioFarma BCG Vaccine for Tuberculosis (TB) Product
Table 99. BioFarma Recent Developments/Updates
Table 100. GSBPL Company Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. GSBPL BCG Vaccine for Tuberculosis (TB) Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Biomed Lublin Company Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Company Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. ANLIS Malbran Company Information
Table 121. ANLIS Malbran Description and Business Overview
Table 122. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product
Table 124. ANLIS Malbran Recent Developments/Updates
Table 125. Fundação Ataulpho de Paiva Company Information
Table 126. Fundação Ataulpho de Paiva Description and Business Overview
Table 127. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product
Table 129. Fundação Ataulpho de Paiva Recent Developments/Updates
Table 130. BB-NCIPD Company Information
Table 131. BB-NCIPD Description and Business Overview
Table 132. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product
Table 134. BB-NCIPD Recent Developments/Updates
Table 135. Torlakinstitut Company Information
Table 136. Torlakinstitut Description and Business Overview
Table 137. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product
Table 139. Torlakinstitut Recent Developments/Updates
Table 140. IVAC – Institute of Vaccines and Medical Biologicals Company Information
Table 141. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
Table 142. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 143. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine for Tuberculosis (TB) Product
Table 144. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
Table 145. Institut Pasteur de Tunis Company Information
Table 146. Institut Pasteur de Tunis Description and Business Overview
Table 147. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 148. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product
Table 149. Institut Pasteur de Tunis Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. BCG Vaccine for Tuberculosis (TB) Distributors List
Table 153. BCG Vaccine for Tuberculosis (TB) Customers List
Table 154. BCG Vaccine for Tuberculosis (TB) Market Trends
Table 155. BCG Vaccine for Tuberculosis (TB) Market Drivers
Table 156. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 157. BCG Vaccine for Tuberculosis (TB) Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Global BCG Vaccine for Tuberculosis (TB) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type: 2024 & 2031
Figure 4. Immune Type Product Picture
Figure 5. Therapy Type Product Picture
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global BCG Vaccine for Tuberculosis (TB) Market Size (2020-2031) & (US$ Million)
Figure 13. Global BCG Vaccine for Tuberculosis (TB) Sales (2020-2031) & (K Dose)
Figure 14. Global BCG Vaccine for Tuberculosis (TB) Average Price (US$/Dose) & (2020-2031)
Figure 15. BCG Vaccine for Tuberculosis (TB) Report Years Considered
Figure 16. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2024
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players: Market Share by Revenue in BCG Vaccine for Tuberculosis (TB) in 2024
Figure 19. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global BCG Vaccine for Tuberculosis (TB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 22. North America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 23. United States BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 26. Europe BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 27. Germany BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2020-2031)
Figure 34. China BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 44. Latin America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 45. Mexico BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2020-2031)
Figure 50. Turkey BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2020-2031)
Figure 54. Global Revenue Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2020-2031)
Figure 55. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Application (2020-2031)
Figure 57. Global Revenue Market Share of BCG Vaccine for Tuberculosis (TB) by Application (2020-2031)
Figure 58. Global BCG Vaccine for Tuberculosis (TB) Price (US$/Dose) by Application (2020-2031)
Figure 59. BCG Vaccine for Tuberculosis (TB) Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Shielded Isolator Market Research Report 2025
Jan 25, 25
Global Compressor Nebulizers Market Research Report 2025
Jan 25, 25
Global Electric Mining Truck Market Research Report 2025
Jan 25, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232